S&P 500   3,795.54
DOW   30,991.52
QQQ   313.92
S&P 500   3,795.54
DOW   30,991.52
QQQ   313.92
S&P 500   3,795.54
DOW   30,991.52
QQQ   313.92
S&P 500   3,795.54
DOW   30,991.52
QQQ   313.92
Log in
NASDAQ:ABCL

AbCellera Biologics Stock Forecast, Price & News

$45.02
-1.62 (-3.47 %)
(As of 01/15/2021 09:10 AM ET)
Add
Compare
Today's Range
$45.02
Now: $45.02
$46.00
50-Day Range N/A
52-Week Range
$36.27
Now: $45.02
$71.91
Volume87 shs
Average Volume1.43 million shs
Market Capitalization$11.96 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for AbCellera Biologics Inc.

MarketRank

Overall MarketRank

1.54 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ABCL
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$11.96 billion
Next Earnings DateN/A
OptionableNot Optionable
$45.02
-1.62 (-3.47 %)
(As of 01/15/2021 09:10 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ABCL News and Ratings via Email

Sign-up to receive the latest news and ratings for ABCL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AbCellera Biologics (NASDAQ:ABCL) Frequently Asked Questions

Is AbCellera Biologics a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AbCellera Biologics in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AbCellera Biologics stock.
View analyst ratings for AbCellera Biologics
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than AbCellera Biologics?

Wall Street analysts have given AbCellera Biologics a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AbCellera Biologics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for ABCL?

5 brokerages have issued 1 year target prices for AbCellera Biologics' shares. Their forecasts range from $45.00 to $59.00. On average, they anticipate AbCellera Biologics' stock price to reach $51.40 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for AbCellera Biologics
or view Wall Street analyst' top-rated stocks.

Who are some of AbCellera Biologics' key competitors?

When did AbCellera Biologics IPO?

(ABCL) raised $356 million in an IPO on Friday, December 11th 2020. The company issued 23,000,000 shares at $14.00-$17.00 per share. Credit Suisse, Stifel, Berenberg, SVB Leerink and BMO Capital Markets acted as the underwriters for the IPO.

What is AbCellera Biologics' stock symbol?

AbCellera Biologics trades on the NASDAQ under the ticker symbol "ABCL."

When does AbCellera Biologics' quiet period expire?

AbCellera Biologics' quiet period expires on Wednesday, January 20th. AbCellera Biologics had issued 24,150,000 shares in its public offering on December 11th. The total size of the offering was $483,000,000 based on an initial share price of $20.00. During AbCellera Biologics' quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of AbCellera Biologics?

Shares of ABCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AbCellera Biologics' stock price today?

One share of ABCL stock can currently be purchased for approximately $46.64.

How big of a company is AbCellera Biologics?

AbCellera Biologics has a market capitalization of $12.39 billion.

This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.